Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib

X. Zhu, Andrew; Kudo, Masatoshi; Assénat, Eric; Cattan, Stéphane; Kang, Yoon‐Koo; Yeong Lim, Ho; T.P. Poon, Ronnie; Blanc, Jean-Frédéric; Vogel, Arndt; Chen, Chao‐Long; Dorval, Étienne; Peck‐Radosavljevic, Markus; Santoro, Armando; Daniele, Bruno; Furuse, Junji; Jappe, Annette; Perraud, Kevin; Anak, Oezlem; Sellami, Dalila; Chen, Li‐Tzong

doi:10.1001/jama.2014.7189

Public

Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib

Published in JAMA • Jul 2, 2014

Authors:

Andrew X. Zhu

Masatoshi Kudo

Eric Assénat

Abstract

IMPORTANCE: Aside from the multikinase inhibitor sorafenib, there are no effective systemic therapies for the treatment of advanced hepatocellular carcinoma. OBJECTIVE: To assess the efficacy of everolimus in patients with advanced hepatocellular carcinoma for whom sorafenib treatment failed. DESIGN...

Subject

Medicine

Everolimus

Sorafenib

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!